1 week Ago By Defense World Staff
KLP Kapitalforvaltning AS acquired a new position in shares of Erasca, Inc. ( NASDAQ:ERAS – Free Report ) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 27,400 shares of the company’s stock, valued at approximately $69,000.
A number of other hedge funds have also recently modified their holdings of ERAS. AXQ Capital LP purchased a new stake in Erasca in the fourth quarter valued at $27,000. Cibc World Markets Corp purchased a new position in shares of Erasca during the fourth quarter worth about $43,000.
New York State Common Retirement Fund increased its position in shares of Erasca by 42.4% during the fourth quarter. New York State Common Retirement Fund now owns 26,859 shares of the company’s stock worth $67,000 after purchasing an additional 8,000 shares in the last quarter.
Teacher Retirement System of Texas lifted its holdings in shares of Erasca by 29.1% in the 4th quarter. Teacher Retirement System of Texas now owns 54,706 shares of the company’s stock valued at $137,000 after purchasing an additional 12,345 shares during the last quarter.
Finally, China Universal Asset Management Co. Ltd. boosted its position in shares of Erasca by 10.
3% in the 4th quarter. China Universal Asset Management Co. Ltd.
now owns 59,949 shares of the company’s stock valued at $150,000 after purchasing an additional 5,614 shares during the period. 67.78% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In ERAS has been the topic of several research analyst reports. Raymond James began coverage on Erasca in a research report on Wednesday, March 26th. They set an “outperform” rating and a $5.
00 price target on the stock. HC Wainwright restated a “buy” rating and set a $6.00 target price on shares of Erasca in a research report on Friday, March 21st.
The Goldman Sachs Group reduced their price target on shares of Erasca from $3.50 to $3.00 and set a “buy” rating for the company in a research report on Friday, March 21st.
Morgan Stanley reiterated an “overweight” rating and set a $4.00 price target on shares of Erasca in a research note on Friday, March 7th. Finally, Bank of America upgraded shares of Erasca from a “neutral” rating to a “buy” rating and set a $5.
00 price objective on the stock in a research note on Tuesday, January 7th. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $4.83.
Erasca Price Performance Erasca stock opened at $1.24 on Friday. The business has a 50 day simple moving average of $1.
42 and a 200-day simple moving average of $2.18. Erasca, Inc.
has a 12 month low of $1.01 and a 12 month high of $3.45.
The stock has a market capitalization of $351.25 million, a PE ratio of -1.49 and a beta of 1.
14. Erasca ( NASDAQ:ERAS – Get Free Report ) last announced its quarterly earnings data on Thursday, March 20th. The company reported ($0.
11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.01.
During the same quarter last year, the firm earned ($0.20) earnings per share. As a group, equities research analysts anticipate that Erasca, Inc.
will post -0.73 EPS for the current year. About Erasca ( Free Report ) Erasca, Inc, a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.
The company’s lead product is naporafenib which is in phase 1b trial for patients with RAS Q16X solid tumors and plans to initiate a pivotal Phase 3 trial for patients with NRASm melanoma. See Also Five stocks we like better than Erasca Transportation Stocks Investing JPMorgan is a Buy, if You Can Handle The Volatility Growth Investing: Should You Adopt This Investing Strategy in 2022? United States Steel’s Crash: An Unmissable Buying Opportunity Consumer Staples Stocks, Explained Rocket Lab Stock: Weathering the Storm, Time for a Comeback? Want to see what other hedge funds are holding ERAS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Erasca, Inc.
( NASDAQ:ERAS – Free Report ). Receive News & Ratings for Erasca Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Erasca and related companies with MarketBeat.com's FREE daily email newsletter .
.
